Effect of Preoperative Oral Carbohydrates on the Glycemic Variability of Diabetic Patients

May 23, 2021 updated by: Yonsei University
Preoperative carbohydrate drink intake attenuate insulin resistance. However, carbohydrate loading may compromise blood glucose control in patients with diabetes. There is some evidence that oral carbohydrate loading may be safe in patients with type 2 diabetes. Therefore, the investigators aim to evaluate whether preoperative carbohydrate intake affects insulin resistance and glycemic variability in patients with diabetes. Fifty patients scheduled for total knee arthroplasty will be divided into carbohydrate (n=25) and control (n=25) groups. Randomly selected patients of the carbohydrate group are given 400ml of 12.8 g/100 ml carbohydrate beverage 2-3 hours before their scheduled operation. In contrast, patients in the control group are fasted from water 2 hours before surgery according to standard protocol.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 03722
        • Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 1. Patients undergoing total knee arthroplasty

Exclusion Criteria:

  • 1. Patients with contraindications to spinal anesthesia (local infection, clotting disorders, anatomical abnormalities, sepsis, etc.)
  • 2. Patients with gastroesophageal reflux disease, gastric emptying disorders, inflammatory bowel disease, or previous treatment for intra-abdominal cancer
  • 3. Patients with chronic renal disease or severe cardiovascular disease
  • 4. HbA1c >69 mmol/mol or BMI >30 kg/m2
  • 5. A duration of ≥5 hours between consumption of CHO and initiation of surgery.
  • 6. The subject is a foreigner or illiterate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: control group
EXPERIMENTAL: carbohydrate group(CHO group)
Randomly selected patients of the carbohydrate group are given oral carbohydrate (400ml) 2-3 hours before surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycemic variability
Time Frame: Before anesthesia
- Coefficient of glucose variability =SD/mean x 100 (%)
Before anesthesia
Glycemic variability
Time Frame: Before anesthesia
- J index=0.001 x (MBG +SD)2 mg/dL
Before anesthesia
Glycemic variability
Time Frame: immediately after anesthesia
- Coefficient of glucose variability =SD/mean x 100 (%)
immediately after anesthesia
Glycemic variability
Time Frame: immediately after anesthesia
- J index=0.001 x (MBG +SD)2 mg/dL
immediately after anesthesia
Glycemic variability
Time Frame: operation end
- Coefficient of glucose variability =SD/mean x 100 (%)
operation end
Glycemic variability
Time Frame: operation end
- J index=0.001 x (MBG +SD)2 mg/dL
operation end
Glycemic variability
Time Frame: 1 hour after surgery
- Coefficient of glucose variability =SD/mean x 100 (%)
1 hour after surgery
Glycemic variability
Time Frame: 1 hour after surgery
- J index=0.001 x (MBG +SD)2 mg/dL
1 hour after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insulin resistance
Time Frame: Before anesthesia
Insulin resistance index = fasting glucose x fasting insulin/22.5
Before anesthesia
Insulin resistance
Time Frame: Before anesthesia
serum laboratory test: glucagon
Before anesthesia
Insulin resistance
Time Frame: Before anesthesia
serum laboratory test: GLP-1
Before anesthesia
Insulin resistance
Time Frame: Before anesthesia
serum laboratory test: C-peptide
Before anesthesia
Insulin resistance
Time Frame: Before anesthesia
serum laboratory test: free fatty acid
Before anesthesia
gastric volume
Time Frame: Before anesthesia
gastric volume measured by ultrasonography.
Before anesthesia
hand grip strength
Time Frame: Before anesthesia
hand grip strength measured by electronic hand dynamometer
Before anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 20, 2019

Primary Completion (ACTUAL)

October 7, 2020

Study Completion (ACTUAL)

October 15, 2020

Study Registration Dates

First Submitted

June 26, 2019

First Submitted That Met QC Criteria

July 3, 2019

First Posted (ACTUAL)

July 9, 2019

Study Record Updates

Last Update Posted (ACTUAL)

May 25, 2021

Last Update Submitted That Met QC Criteria

May 23, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 4-2019-0428

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes

Clinical Trials on carbohydrate group

3
Subscribe